Tag:#Cannabis Capital Markets

Polish Cannabis Blockchain Start-Up Receives €400,000 Investment To Deliver Seed-To-Sale Supply Chain Security

TRUSTT has secured €400,000 in pre-seed funding to finance its ambitious blockchain tracing platform, which it believes will allow it to become a leading...

Danish Biotech Firm Secures €2m Funding To Support Its Pharma-Focused Medical Cannabis Vision

TETRA Pharm has successfully completed its first external funding round raising €2m in capital to help it launch clinical trials and expand its operations...

Investors Respond Positively To Senior Appointment At Under-Fire UK CBD Firm

CHILL Brands Group saw its stock prices jump as much as 25% after announcing the appointment of Michael Sandore as its new head of...

Will 2022 Be The Year When A Maturing European Cannabis Industry Becomes Mainstream?

FUELLED by last year’s significant progress the European cannabis industry is looking forward to further positive developments in 2022. While there may have been a...

2022 Will See The Race To The Bottom Replaced By A Healthy Focus On Profitable Business Models

Stenocare CEO Thomas Skovlund Schnegelsberg reflects on 2021 and looks ahead to the challenges and opportunities that lie ahead in 2022 BC: What are the main opportunities...

A Ground-Breaking Year For European Cannabis Mapped Out In BusinessCann’s 2021 Top 10

THIS has been a remarkable year for European cannabis with some significant milestones passed on an increasingly fruitful trek into the post-prohibition era. Top of...

CBD Consumers Want Trusted Brands And High-Quality Products Backed By Regulators and Retailers

In a Q&A with BusinessCann Eoin Keenan, CEO & Co-Founder, Goodrays, says after seven years working in the industry he expects 2022 to be...

Buy-And-Build Cannabis Company Pivots to Adult-Use Opportunities In Its Domestic Market

GERMAN firm SynBiotic has just completed what it calls the ‘most significant merger in the European cannabis sector’ to date, as it considers how...

Latest news

European Cannabis Stocks Review: Celadon Shares Spike 150% On Licence Update, OCT Continues Recovery, & Creso Pharma Censured By ASX

Celadon Pharmaceuticals  Celadon Pharmaceuticals stock has skyrocketed by more than 150% this week following the announcement that its current Home...
- Advertisement -spot_imgspot_img

Benefits of F1 Cannabis Hybrids from Royal Queen Seeds

F1 hybrids have revolutionised the way we grow and use plants. Now, F1 cannabis seeds are bringing growers, smokers,...

Celadon Pharmaceuticals Announces Home Office Approval Of Licence For Commercial Sale Of GMP Cannabis

PRESS RELEASE FURTHER to the announcement dated 16 January 2023, Celadon Pharmaceuticals Plc (AIM: CEL), a UK-based pharmaceutical company focused on...

Must read